Search clinical trials for: Quantiferon

Total 54 results

University Hospital, Grenoble

Not yet recruiting

Quantiferon CMV to Identify Treatment Need For Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT) (QUANTIFOT)

Liver Transplantation | Kidney Transplantation | Heart Transplantation | Cytomegalovirus Infections | Lung Transplantation

France
Tulane University
Johns Hopkins Bloomberg School of Public Health; Universidad Peruana Cayetano... and other collaborators

Not yet recruiting

Diagnostic Innovations for Pediatric Tuberculosis in Bolivia

Tuberculosis
Huashan Hospital
Guizhou Center for Disease Control and Prevention

Recruiting

Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients

Tuberculosis | Latent Tuberculosis Infection

China
Huashan Hospital
The Second Hospital of Hebei Medical University; Tongji Hospital; The Affiliated... and other collaborators

Recruiting

The Prevalence and Reproductive Outcome of Infertile Women With Genital Tuberculosis (TB-PRIME)

Infertility, Female | Genital Tuberculoses, Female

China
Centre Hospitalier Universitaire de Saint Etienne

Recruiting

QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis (RECOHFERRON)

Cytomegalovirus Infections

France
Centre Hospitalier Universitaire Dijon

Recruiting

Evaluation of a Functional Lymphocyte Test (QuantiFERON Monitor®) as a Prognostic Marker for Acute Community-acquired Pneumonia (LYMPHONIE)

Pneumonia

France
Centre Hospitalier Universitaire de Nice

Completed

Functional Non Specific Immunity Monitoring After Kidney Transplantation Using an Interferon Gamma Test (QuantiFERON)

Kidney Transplantation

France
Centre Hospitalier Universitaire de Saint Etienne

Terminated

Evaluation and Longitudinal Follow-up of Biomarkers Predictive of Severe Forms of COVID-19 (COVIMMUNITY)

Covid19

France
University of Oklahoma

Completed

Screening Strategy for Early Diagnosis of Silicosis in At-Risk Populations in Oklahoma

Silicosis | Pneumoconiosis; Silica

United States
Centre Hospitalier Universitaire de Nice

Withdrawn

Evaluation of Sepsis-induced Immunosuppression Base on QuantiFERON Monitor® in Septic Shock (MONITOR SEPSIS)

Septic Shock
Henry M. Jackson Foundation for the Advancement...
Infectious Diseases Clinical Research Program

Completed

Screening for Latent Tuberculosis Infection (LTBI) in US Army Recruits (LTBI)

Latent Tuberculosis Infection

United States
University of Milano Bicocca
San Gerardo Hospital

Completed

Evaluation of the Immune Response to Sars-Covid-19 Vaccines in Haematological Patients: Prospective Single Center Study (Hema-C19-Vax)

Hematologic Diseases

Italy
University Health Network, Toronto
Canadian National Transplant Research Program

Completed

Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients (QFT-CMV)

Cytomegalovirus Viraemia

Spain, Canada
Biomedical Research Center EPLS
University of Cape Town; Biofabri, S.L; TuBerculosis Vaccine Initiative; Universidad... and other collaborators

Completed

Epidemiological Study In Tuberculosis-Endemic Urban Area in Senegal (MTBVAC-EPI)

Tuberculosis

France
Assistance Publique - Hôpitaux de Paris

Completed

Paradoxical Reactions in Non Immuno-compromized Patients With Extrapulmonary Tuberculosis (PARATB)

Extrapulmonary Tuberculosis

France
University of Lausanne Hospitals

Completed

Cell-mediated Immunity for Prevention of CMV Disease

Cytomegalovirus Infections

Switzerland
Centers for Disease Control and Prevention

Completed

Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis

Tuberculosis | Latent Tuberculosis Infection

United States
QIAGEN Gaithersburg, Inc

Terminated

Clinical Evaluation of the QuantiFERON CMV Assay

CMV

United States
QIAGEN Gaithersburg, Inc

Withdrawn

QuantiFERON Access Clinical Performance Study Protocol

Tuberculosis (TB)
University Hospital, Grenoble

Completed

Anti-CMV Cellular Immunity Quantification Using an IGRA Test in Kidney Transplant récipients and Hemodialysis Patients, Comparison to Control Patients (Quantiferon)

Hemodialysis | Kidney Transplant Infection | Cytomegalovirus Infections | Quantiferon-CMV

France
Huashan Hospital

Completed

Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention

Tuberculosis | Silicosis

China
University of Pittsburgh
Cellestis

Withdrawn

Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation

Chronic Liver Disease | TB

United States
University Hospital, Limoges

Terminated

Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®-CMV Test. (QUANTIC-R+)

Renal Transplant Recipient | Immunized Against the Cytomegalovirus

France
Johns Hopkins University
National Institute of Allergy and Infectious Diseases (NIAID); University of...

Completed

Quantiferon Gold Test for Detecting Tuberculosis (TB) Infection in HIV/AIDS Patients in South Africa

HIV | Latent Tuberculosis

South Africa
QIAGEN Gaithersburg, Inc

Completed

Evaluation of the QuantiFERON-TB Test.

Tuberculosis

United States
QIAGEN Gaithersburg, Inc

Completed

Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection

Tuberculosis

United States
QIAGEN Gaithersburg, Inc

Completed

Evaluation of the QuantiFERON-TB Test.

Tuberculosis

United States
QIAGEN Gaithersburg, Inc

Completed

Evaluation of the QuantiFERON-TB Test.

Tuberculosis

United States
University of Sao Paulo General Hospital

Unknown

Cytomegalovirus Risk in Seropositive Kidney Transplant Recipients Stratified by Quantiferon-CMV

Kidney Transplant Infection | CMV | Cytomegalovirus Infections

Brazil
Deepali Kumar

Completed

Clinical Evaluation of Quantiferon-Monitor to Predict Outcomes in Solid Organ Transplant Recipients (QTF-Monitor)

Immunity, Cellular

Canada
Clinical Hospital Merkur
Clinical Hospital Centre Zagreb

Unknown

Evaluation of Cell-mediated Immune Response by QuantiFERON Monitor® Assay in Kidney Transplant Recipients

Kidney Transplant Infection | Kidney Transplant Rejection

Croatia
University Health Network, Toronto

Completed

Cell Mediated Immunity for Secondary Prophylaxis in CMV SOT Patients (Q-CMV)

Cytomegalovirus Viraemia

Canada
National Taiwan University Hospital

Unknown

Comparing Consistency of QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold for Latent Tuberculosis in Dialysis Population

Patients on Dialysis

Taiwan
Fundacio Catalana de Pneumologia
Roche Farma, S.A

Completed

Cytomegalovirus-Specific Response Measured by QuantiFeron® and Overall Immunologic Response Measured by ImmuKnow® in Lung Transplant Patients CMV-positive (REIVI)

Cytomegalovirus Infections

Spain
Hospital Universitari de Bellvitge
Cellestis

Completed

QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study. (OPTIMIST)

Latent Tuberculosis Infection

Spain
Statens Serum Institut

Completed

A Trial in Subjects Suspected to Have Tuberculosis, Comparing the Diagnostic Performance of C-Tb to QuantiFERON®, in Combination With a Safety Assessment of C-Tb Versus Tuberculin PPD RT23 SSI

Tuberculosis

South Africa
QIAGEN Gaithersburg, Inc

Terminated

Performance Comparison of QuantiFERON Monitor in Solid Organ Transplant Recipients

Cell-mediated Immune Response

United States
Tuberculosis Network European Trialsgroup

Completed

T Cell Interferon-gamma Release Assay (TIGRA) in Immunocompromised Individuals (TBNET-TIPS)

Tuberculosis | Monitoring, Immunologic

Denmark, United Kingdom, Sweden, Australia, Bulgaria, Germany, Greece, Italy, Netherlands, Portugal, Romania, Spain, Switzerland, Turkey
Statens Serum Institut

Completed

Comparison of Diagnostic Performance of C-Tb to QuantiFERON®-TB, in Combination With a Safety Assessment of C-Tb vs Tuberculin PPD RT23 SSI

Tuberculosis

Spain
Yonsei University

Completed

Conversion Rate of (TST) Tuberculin Skin Test and Quantiferon-TB Gold In Tube Assay in Health Care Workers

Tuberculosis

Korea, Republic of
South East Asia Research Collaboration with Hawaii
Columbia University; Queen Sirikit National Institute of Child Health; New York... and other collaborators

Completed

Improving Latent Tuberculosis (TB) Diagnosis in Thai Children (TB Px)

HIV Infections | Latent Tuberculosis

Thailand
University of Alberta

Completed

Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients

Cytomegalovirus Infection

Canada
Assistance Publique - Hôpitaux de Paris

Completed

Quantiferon for Detection of Latent Tuberculosis in Healthcare Workers (QUANTIPS)

Tuberculosis

France
University of Roma La Sapienza

Completed

A Study on Changes in IFN-gamma Levels Following Anti-TNF Treatment in Patients Undergoing Serial QuantiFERON-TB Gold In-Tube

Inflammatory Rheumatic Diseases
French National Agency for Research on AIDS and...

Completed

Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT

HIV Infections | Tuberculosis

France
Tel-Aviv Sourasky Medical Center

Unknown

Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis

Psoriasis | Tuberculosis

Israel
Armed Forces Capital Hospital, Republic of Korea

Completed

The Clinical Utility of QuantiFERON in the Diagnosis of Active Tuberculosis

Tuberculosis

Korea, Republic of
Armed Forces Capital Hospital, Republic of Korea

Completed

QuantiFERON Change During Anti-tuberculosis Medication

Tuberculosis | Interferon-gamma Release Assay

Korea, Republic of
Armed Forces Capital Hospital, Republic of Korea

Completed

The Time of Positive Conversion of Interferon-γ Releasing Assay After Tuberculosis Exposure

Tuberculosis
Walter Reed Army Medical Center
National Naval Medical Center

Unknown

Comparison of the Tuberculin Skin Test (TST) and QuantiFERON ®-TB Gold Test (QFT-G) In Patients With Rheumatoid Arthritis Being Considered for Anti-TNF-Alpha Therapy

Rheumatoid Arthritis | Tuberculosis

United States

Search clinical trials for: Quantiferon

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations